Japan Generics Policy To Spark Mergers Among Makers
This article was originally published in PharmAsia News
Executive Summary
Japan's inauguration of a generics promotion campaign in April is expected to lead to an increase in consolidations by makers of the drugs. The Japan generics market, counted at $3.41 billion in 2006, is expected to grow sharply after the new policy gets under way. The policy spurs a need for generics makers to become bigger so they can serve a larger market. Nichiiko Pharmaceutical-Teikoko Medix KK, Zydus Cadilla Group-Nippon Universal Pharmaceutical and India's Lupin and Kyowa Pharmaceutical are examples of recent mergers. (Click here for more - a subscription may be required)